• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Tiffany Turner

Tiffany Turner

Articles

ARTICLES

Alnylam Signs Potential $1B RNAi Agreement with Takeda

May 28, 2008
By Tiffany Turner
Alnylam Pharmaceuticals Inc. took another step in advancing its RNAi portfolio Tuesday, inking a potential $1 billion deal with Tokyo-based Takeda Pharmaceutical Co. Ltd. that will give Cambridge, Mass.-based Alnylam a 50-50 share in the Japanese partner's development and commercialization efforts in RNAi therapeutics in the U.S. (BioWorld Today)
Read More

Blood Substitutes Struggle in Sea of Toxicity Concerns

May 26, 2008
By Tiffany Turner
Although blood shortages are common in much of the developing world and industrialized nations alike, the few players in the blood substitute market have much work to do to achieve success in that space. And it doesn't help that recent events threatened to send companies like Biopure Corporation, Hemosol BioPharma Inc. and Northfield Laboratories Inc. back to the starting block. (BioWorld Financial Watch)
Read More

Biotech Start-up's Pet Clone Auction Raises Ethical Concerns

May 22, 2008
By Tiffany Turner

Pharmacopeia Soars on Data for New Blood Pressure Med

May 19, 2008
By Tiffany Turner

Wall Street Analysts Prepare for ASCO Flood Starting Friday

May 15, 2008
By Tiffany Turner

ImaRx Shares Spike on Sale of Urokinase to Microbix

May 8, 2008
By Tiffany Turner
In a deal that sent shares of ImaRx Therapeutics Inc. soaring and spurred the creation of a spin-off company, Microbix Biosystems agreed to acquire urokinase inventory and related assets from ImaRx for $17 million in cash. (BioWorld Today)
Read More

Critical Therapeutics Investors Balk Over Cornerstone Merger

May 5, 2008
By Tiffany Turner

Esperion Spins Out of Pfizer, Brings in $22.8M in Series A

May 2, 2008
By Tiffany Turner
Four years after purchasing Esperion Therapeutics Inc., a company focused on the discovery and development of compounds for cardiovascular and metabolic disease, Pfizer Inc. is selling the Ann Arbor, Mich.-based firm to an entity funded by a group of investors. (BioWorld Today)
Read More

Concert Raises $37M to Boost Deuterium Modification Platform

May 1, 2008
By Tiffany Turner

Isis Shares Slip on Need for Mipomersen Data

April 28, 2008
By Tiffany Turner
View All Articles by Tiffany Turner

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 10, 2025.
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 8, 2025
  • Antibodies

    Abbvie gains rights to IGI’s trispecific ISB-2001 in $1.9B+ deal

    BioWorld
    Nearly six years after Ichnos Sciences Inc. launched operations, a subsidiary of the now-named Ichnos Glenmark Innovation (IGI) Inc. has signed with Abbvie Inc. a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe